Align Technology | ALGN - Selling And Administration Expenses

Stock Price
158.47
Daily Change
-2.06 -1.28%
Monthly
-14.35%
Yearly
-15.84%
Q2 Forecast
165.29

Align Technology reported $465.34M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
3M USD 744M 221M Mar/2026
Align Technology USD 465.34M 23.67M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Bruker USD 242.1M 5.1M Mar/2026
Cardinal Health USD 1.51B 6M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cooper Companies USD 373.1M 46.1M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 351M 32M Mar/2026
Dexcom USD 349.7M 49.8M Mar/2026
Henry Schein USD 809M 1000K Mar/2026
Idexx Laboratories USD 299.85M 24.18M Mar/2026
Insulet USD 317.2M 14.2M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Masimo USD 143.4M 15.4M Mar/2026
McKesson USD 1.8B 234M Mar/2026
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Solventum Corp USD 783M 24M Mar/2026
Stryker USD 2.15B 17M Mar/2026
Teleflex USD 226.01M 3.64M Mar/2026
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Veeva Systems USD 125.08M 3.11M Dec/2025
Waters USD 394M 153.99M Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026
Zoetis USD 588M 31M Mar/2026